These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 28760312)

  • 1. Adjuvant Therapy for Non-Clear Cell Renal Cell Carcinoma-The Ascent Continues.
    Brown JT
    JAMA Netw Open; 2024 Aug; 7(8):e2425251. PubMed ID: 39106073
    [No Abstract]   [Full Text] [Related]  

  • 2. Abrocitinib-A promising option for patients with refractory bullous pemphigoid.
    Jiang W; Ma X; Guo T; Song M; Zhang J
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):e119-e121. PubMed ID: 37653285
    [No Abstract]   [Full Text] [Related]  

  • 3. New treatment options for metastatic renal cell carcinoma.
    Rodriguez-Vida A; Hutson TE; Bellmunt J; Strijbos MH
    ESMO Open; 2017; 2(2):e000185. PubMed ID: 28761748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity.
    Schinzari G; Monterisi S; Signorelli D; Cona MS; Cassano A; Danza F; Barone C
    Tumori; 2014; 100(6):e298-300. PubMed ID: 25688515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good tolerability, long-term survival and easy management of side effects in a patient with metastatic renal cell carcinoma treated with pazopanib.
    Frascaroli M; Di Cesare P
    Tumori; 2014; 100(6):e301-4. PubMed ID: 25688516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tyrosine kinase inhibitor as adjuvant treatment of renal cell carcinoma: 1 versus 3].
    Penel N
    Bull Cancer; 2017 Sep; 104(9):705-706. PubMed ID: 28760312
    [No Abstract]   [Full Text] [Related]  

  • 7. Pazopanib: an oral multitargeted tyrosine kinase inhibitor for use in renal cell carcinoma.
    LaPlant KD; Louzon PD
    Ann Pharmacother; 2010 Jun; 44(6):1054-60. PubMed ID: 20407031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pazopanib in renal cell carcinoma.
    Ward JE; Stadler WM
    Clin Cancer Res; 2010 Dec; 16(24):5923-7. PubMed ID: 21059813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pazopanib for the treatment of renal cell carcinoma and other malignancies.
    Sonpavde G; Hutson TE; Sternberg CN
    Drugs Today (Barc); 2009 Sep; 45(9):651-61. PubMed ID: 19956806
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.